ISSAR Pharma announces out-licensing of its Peptide-based NCEs
Apr 29, 2021
Hyderabad (Telangana) [India], April 29 (ANI/PNN): ISSAR Pharmaceuticals, pioneers in Peptide Technology and peptide drug innovation, has decided to license out their peptide-based New...